15PA pilot study of single pegfilgrastim compared with intermittent every other days of 5 shot-filgrastim in breast cancer patients receiving adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy (G-CSF 105 trial: NCT02685111). (25th November 2018) - Jeong, J; Sohn, B S; Ahn, J-H; Jung, K H; Kim, J E; Oh, J; Lee, H; Sohn, J H; Koh, S-J; Seo, J H; Lee, K S; Kim, S-B